ICON2 trial. UK consensus statement on standard practice for chemotherapy in ovarian cancer
- PMID: 10029003
ICON2 trial. UK consensus statement on standard practice for chemotherapy in ovarian cancer
Comment on
-
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. ICON Collaborators. International Collaborative Ovarian Neoplasm Study.Lancet. 1998 Nov 14;352(9140):1571-6. Lancet. 1998. PMID: 9843101 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
